(EMAILWIRE.COM, December 22, 2010 )
NEW YORK, NY - MyBestPicksEver, publishers of free Stock and News alerts, reports on the following stock performances for (NASDAQ:RNWK) RealNetworks Inc. is a strong company who currently resides in the Technology sector of the Internet Software & Services industry. They are currently trading at a price of $4, which is a difference of 1.52% from its previous day's close. Currently, RealNetworks Inc. has an extremely high market capital of approximately 534.54M. On top of that, the company has done quite well today as the stock is trading at a volume of 146,803 compared to its daily average volume of 742,880. RNWK is trading with a gain of 0.76% from its open this morning. Over the last 52 weeks RNWK has done nicely as they are -26.06% below its 52 week high and 54.44% above its 52 week low.RealNetworks, Inc. provides network-delivered digital media products and services worldwide. It develops and markets software products and services that enable the creation, distribution, and consumption of digital media, including audio and video. The company operates in four segments: Technology Products and Solutions (TPS), Media Software and Services (MSS), Games, and Music. The TPS segment primarily offers software-as-a-service offerings, which include ringback tones, music-on-demand, video-on-demand, and messaging services, as well as system software license sales and intellectual property licensing. This segment also licenses Helix server software that allows companies to broadcast live and on-demand audio, video, and other multimedia programming to users over the Internet. The MSS segment offers RealPlayer, a media player software, which includes features and services that enable consumers to discover, play, download, manage, and edit digital video. The Games segment offers various casual games available through digital downloads or online portals, social networks, and mobile devices. This segment also involves in game development, publishing, licensing, and distribution. It distributes games principally in North America, Europe, and Latin America through the companys own Web sites, which are operated under the GameHouse, RealArcade, Zylom, and Atrativa brands, and through Web sites owned or managed by third parties. In addition, this segment develops and distributes games for other platforms, including mobile phones, other handheld devices, and videogame consoles. The Music segment offers Rhapsody, a subscription and advertising-supported music service; Rhapsody.com, a free Web-based limited version digital music service; and Rhapsody MP3 music store, where consumers purchase and download individual digital music tracks. The company was founded in 1994 and is headquartered in Seattle, Washington.
(NASDAQ:LXRX) Lexicon Pharmaceuticals, Inc. is a strong company who currently resides in the Healthcare sector of the Biotechnology industry. They are currently trading at a price of $1.59, which is a difference of 1.92% from its previous day's close. Currently, Lexicon Pharmaceuticals, Inc. has an extremely high market capital of approximately 526.61M. On top of that, the company has done quite well today as the stock is trading at a volume of 301,619 compared to its daily average volume of 931,450. LXRX is trading with a gain of 1.27% from its open this morning. Over the last 52 weeks LXRX has done nicely as they are -44.60% below its 52 week high and 35.9% above its 52 week low.Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The companys drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolutions Chemetics platform chemistry technology. The company was founded in 1995 and is headquartered in The Woodlands, Texas.
A new revolutionary form of Penny Stock trading is here. Its called honest, up front Information provided to you by MyBestPicksEver.
MBPE is a company brought up on integrity, honesty, and pure communication. We are here to provide the very Best picks ever , giving you information that you can only find here. http://mybestpicksever.com/about-2/
MyBestPicksEver is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. All information provided on this website pertaining to investing, stocks, securities must be understood as information provided and not investment advice. We advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks any stock including those featured on MyBestPicksEver.Com . All information provided regarding the companies featured on this web site comes from the companies themselves, SEC filings, news releases, company web as well as other sources of publicly available information.